TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan
· Delayed Price · Currency is TWD 51.00
0.00 (0.00%)
Mar 10, 2026, 1:30 PM CST
TSH Biopharm Corporation Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,958 | 2,246 | 2,354 | 1,931 | 1,826 | 1,709 | Upgrade
|
| Market Cap Growth | -14.86% | -4.57% | 21.87% | 5.78% | 6.85% | -24.45% | Upgrade
|
| Enterprise Value | 1,757 | 1,610 | 1,785 | 1,230 | 1,111 | 926 | Upgrade
|
| Last Close Price | 51.00 | 58.50 | 58.74 | 47.23 | 43.09 | 38.91 | Upgrade
|
| PE Ratio | 14.09 | 16.13 | 20.81 | 31.16 | 29.50 | 36.27 | Upgrade
|
| PS Ratio | 1.47 | 1.68 | 2.11 | 2.38 | 2.46 | 4.13 | Upgrade
|
| PB Ratio | 1.14 | 1.31 | 1.45 | 1.53 | 1.51 | 1.58 | Upgrade
|
| P/TBV Ratio | 1.70 | 1.95 | 2.13 | 1.83 | 1.77 | 1.58 | Upgrade
|
| P/FCF Ratio | 14.51 | 16.64 | 12.93 | 67.79 | 59.62 | 25.01 | Upgrade
|
| P/OCF Ratio | 14.04 | 16.10 | 12.81 | 57.02 | 53.15 | 24.87 | Upgrade
|
| EV/Sales Ratio | 1.31 | 1.21 | 1.60 | 1.52 | 1.50 | 2.24 | Upgrade
|
| EV/EBITDA Ratio | 7.17 | 6.57 | 9.64 | 15.84 | 14.02 | 15.21 | Upgrade
|
| EV/EBIT Ratio | 8.04 | 7.37 | 10.51 | 19.33 | 16.83 | 16.65 | Upgrade
|
| EV/FCF Ratio | 13.01 | 11.93 | 9.81 | 43.18 | 36.28 | 13.55 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.08 | 0.10 | 0.09 | 0.73 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 0.14 | 0.14 | 0.11 | 0.26 | 2.06 | 0.07 | Upgrade
|
| Net Debt / Equity Ratio | -0.28 | -0.28 | -0.54 | -0.60 | -0.62 | -0.67 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.94 | -1.94 | -4.74 | -9.85 | -9.49 | -11.97 | Upgrade
|
| Net Debt / FCF Ratio | -3.53 | -3.53 | -4.82 | -26.84 | -24.58 | -10.67 | Upgrade
|
| Asset Turnover | 0.71 | 0.71 | 0.69 | 0.57 | 0.57 | 0.35 | Upgrade
|
| Inventory Turnover | 3.95 | 3.95 | 3.62 | 3.64 | 3.89 | 2.20 | Upgrade
|
| Quick Ratio | 3.57 | 3.57 | 5.32 | 7.35 | 4.96 | 9.72 | Upgrade
|
| Current Ratio | 6.27 | 6.27 | 6.25 | 8.34 | 5.56 | 10.72 | Upgrade
|
| Return on Equity (ROE) | 11.24% | 11.24% | 9.29% | 5.24% | 5.76% | 4.26% | Upgrade
|
| Return on Assets (ROA) | 7.20% | 7.20% | 6.55% | 2.81% | 3.17% | 2.90% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.07% | 17.58% | 21.06% | 11.30% | 13.19% | 11.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.70% | 12.70% | 10.40% | 5.00% | 5.40% | 5.10% | Upgrade
|
| Earnings Yield | 7.11% | 6.20% | 4.81% | 3.21% | 3.39% | 2.76% | Upgrade
|
| FCF Yield | 6.89% | 6.01% | 7.73% | 1.47% | 1.68% | 4.00% | Upgrade
|
| Dividend Yield | 4.07% | - | 3.61% | 2.71% | 3.71% | 3.85% | Upgrade
|
| Payout Ratio | 58.45% | 58.45% | 43.46% | 99.11% | 93.06% | 146.72% | Upgrade
|
| Buyback Yield / Dilution | -0.05% | -0.05% | -0.04% | 0.05% | -0.05% | -0.01% | Upgrade
|
| Total Shareholder Return | 4.01% | -0.05% | 3.57% | 2.76% | 3.66% | 3.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.